Skip to content

Comparison of ondansetron and meperidine for prevention of postoperative shivering

Comparison of ondansetron and meperidine for prevention of postoperative shivering in patients undergoing General Anesthesia for lower extremity surgery

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201106096758N1
Enrollment
105
Registered
2011-08-13
Start date
2010-10-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases of the nervous system. Disorders of autonomic nervous system

Interventions

Intervention 1: Intervention: :M(meperidine) 25mg /IV imediately before of induction . Intervention 2: Intervention: O(ondansetron) 4mg /IV imediately before of induction. Intervention 3: Control:
Prevention
Intervention: :M(meperidine) 25mg /IV imediately before of induction .
Intervention: O(ondansetron) 4mg /IV imediately before of induction
Control: C(saline) 2mg /IV

Sponsors

vice-chancellor for research of Qazvin universityof medical science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion: Graps Triminol ;20-60years old ;Asa class 1,2,3 ;Under going general anesthesia for lower extremity surgery exclusion:Cardiovascular disease ,psychiatric dis, thyroid dis, drug allergic reaction - body temperature = 38 or = 36.3 ° c – DM – obesity – procedures which require administration of blood and blood products & anticipated duration more than 180 min.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Post operative cheels. Timepoint: Twice(between 5-15min). Method of measurement: 4 point scale.

Secondary

MeasureTime frame
Sao2. Timepoint: -. Method of measurement: between 1-100.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Mohamad Ghasem Roshanferkr Balalemi

Qazvin University of Medical Sciences

mgroshanfekr@qums.ac.ir+98 28 1332 0107

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026